EGFR antagonist, Cetuximab is used in cases of
Palliative treatment of head and neck cancer
Anal canal carcinoma
Gastric carcinoma
Small cell lung carcinoma
Cetuximab and pemtumomab are directed against the epidermal growth factor receptor (EGFR), a transmembrane glycoprotein involved in signaling pathways affecting growth and proliferation of tumor cells. Both cetuximab and pemtumomab, when given alone, have been shown to benefit a small propoion of previously treated patients
All India exam